IVF vs AVR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

IVF

39.8
AI Score
VS
AVR Wins

AVR

41.7
AI Score

Investment Advisor Scores

IVF

40score
Recommendation
AVOID NEW MONEY

AVR

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVF AVR Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 16.7% 63.3% AVR
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.8/100 41.7/100 AVR
Profit Margin -92.3% 0.0% AVR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD AVR

Relative Price Performance (Last 90 Days)

IVF 1M: -47.7% · 3M: -46.7% AVR 1M: -21.3% · 3M: -26.2%

Current Technical Phase

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 21

RSI (14): 20.7 · Price: $0.53

AVR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 27

RSI (14): 27.1 · Price: $6.00

Fundamentals Snapshot

Metric IVF AVR
Market Cap — —
Forward P/E -0.1 -5.2
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.4% 0.7%
Operating Margin -0.6% -30.7%
EPS 127.95 -1.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.